Experimental T-Cell therapy for liver cancer halted early
NCT ID NCT04502082
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 20 times
Summary
This study tested a new treatment called ET140203 T cells for people with advanced liver cancer that had not responded to other therapies. The treatment involved taking a patient's own immune cells, modifying them to target cancer, and giving them back. The study was stopped early after enrolling only 8 participants, so the full safety and effectiveness are not known.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
-
Kansas University Medical Center
Westwood, Kansas, 66205, United States
Conditions
Explore the condition pages connected to this study.